Form 8-K - Current report:
SEC Accession No. 0001104659-25-016145
Filing Date
2025-02-21
Accepted
2025-02-21 16:16:12
Documents
14
Period of Report
2025-02-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm257187d1_8k.htm   iXBRL 8-K 27188
  Complete submission text file 0001104659-25-016145.txt   240691

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbio-20250219.xsd EX-101.SCH 3266
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbio-20250219_def.xml EX-101.DEF 26194
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20250219_lab.xml EX-101.LAB 35952
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20250219_pre.xml EX-101.PRE 24852
16 EXTRACTED XBRL INSTANCE DOCUMENT tm257187d1_8k_htm.xml XML 4785
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 25652106
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)